Trial intelligence / Profile preview

iFAAM-PPI: Impact of PPIs on Walnut Allergy Threshold

NCT02552537Phase 4Completed

Sponsor
University of Zurich
Start
Sep 2015
Primary completion
Mar 2017
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of omeprazole, sponsored by University of Zurich. Started Sep 2015; status: completed.

02

Drugs

omeprazole

Beyond the preview

Go deeper on NCT02552537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02552537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call